Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 randomized, double-blind trial comparing placebo and atomoxetine once daily in adults with attention-deficit/hyperactivity disorder;…
-
FDA approval · 2010-10-18FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the methylphenidate transdermal system (a patch) for ADHD, submitted by PADAGIS US LLC.
-
FDA approval · 2010-10-18FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) submitted by Shionogi Inc.
-
FDA approval · 2010-10-18FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc. under NDA 021259, authorizing co…
-
CLINICAL_TRIALS trial_result · 2010-10-14Clinical Trial Update: Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD [Phase 4]
A Phase 4 trial comparing methylphenidate, dextroamphetamine, and placebo in children with ADHD has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents [Phase 3]
Phase 3 trial conducted by Göteborg University evaluating omega-3/omega-6 fatty acids for Attention-Deficit/Hyperactivity Disorder in childr…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: CONCERTA Lab School Study [Phase 4]
A Phase 4 clinical trial update for CONCERTA Lab School Study in children with Attention Deficit Hyperactivity Disorder has completed with r…
-
FDA approval · 2010-09-23FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a Sandoz generic combination of four amphetamine salt components (dextroamphetamine and amphetam…
-
FDA approval · 2010-09-16FDA Approved: ATOMOXETINE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder, manufactured …
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of GTS-21 in adults with ADHD; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE [Phase 4]
A Phase 4 pilot trial evaluating atomoxetine for ADHD symptoms in adolescents with cannabis use disorder was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents [Phase 4]
A Phase 4 clinical trial evaluating the effects of a once-daily dose of atomoxetine on ADHD-related insomnia in children and adolescents has…
-
CLINICAL_TRIALS research · 2010-08-10Clinical Trial Update: Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder
This entry notes a clinical trial investigating event-related potentials as a tool in managing children with Attention-Deficit/Hyperactivity…
-
FDA approval · 2010-07-29FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2010-07-28FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) submitted by Mylan Institutional LLC. This action confirms ap…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder [Phase 4]
This document summarizes the completion of a Phase 4 double-blind randomized trial comparing galantamine hydrobromide to placebo in adults w…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Concerta Treatment in Adults With ADHD NOS [Phase 4]
A Phase 4 clinical trial evaluating Concerta (methylphenidate) for adults with ADHD NOS has been completed.
-
CLINICAL_TRIALS research · 2010-07-01Clinical Trial Update: Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities [NA]
A clinical trial update for a study on working memory training in college students with Attention-Deficit/Hyperactivity Disorder; sponsor is…
-
FDA approval · 2010-06-29FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the methylphenidate transdermal system for attention-deficit/hyperactivity disorder.
-
FDA approval · 2010-06-23FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc. under ANDA070976.
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 trial comparing atomoxetine to placebo in children with attention-deficit/hyperactivity disorder; results were posted after completi…
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
This trial update reports on a study comparing self-administered versus clinician-administered rating scales in patients with Attention-Defi…
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS) [Phase 4]
Phase 4 trial update for Strattera in adults with ADHD NOS completed; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy [Phase 4]
Phase 4 trial evaluating Strattera (atomoxetine) for children with ADHD who have a poor response to stimulant therapy has completed. This up…
-
CLINICAL_TRIALS research · 2010-05-28Clinical Trial Update: Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This clinical trial update describes a classroom-level behavioral intervention intended to promote peers' acceptance of children with Attent…